A detailed history of Strs Ohio transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 2,200 shares of AVTE stock, worth $5,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,200
Previous 2,200 -0.0%
Holding current value
$5,632
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$17.68 - $29.57 $1,768 - $2,957
-100 Reduced 4.35%
2,200 $65,000
Q2 2023

Jul 31, 2023

BUY
$15.63 - $22.01 $35,949 - $50,623
2,300 New
2,300 $39,000
Q3 2021

Oct 22, 2021

BUY
$11.76 - $22.49 $27,048 - $51,727
2,300 New
2,300 $48,000

Others Institutions Holding AVTE

About Aerovate Therapeutics, Inc.


  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $62.6M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.